Updates in thrombosis in pediatrics: where are we after 20 years? Journal Articles

abstract

• AbstractThe incidence of venous thromboembolism (VTE) in the pediatric population is increasing. Technological advances in medicine and imaging techniques, improved awareness of the disease, and longer survival of life-threatening or chronic medical conditions all contribute to the increase in VTE rates. There is a paucity of data on management of VTE based on properly designed clinical trials, but there is significant advancement in the last 2 decades. This review summarizes the progress made in pediatric thrombosis, including epidemiological changes, advances in anticoagulant agents, and outcomes of VTE.

authors

• Chan, Anthony
• Monagle, Paul

status

• published 

publication date

• December 8, 2012

has subject area

• Adolescent (MeSH)
• Anticoagulants (MeSH)
• Child (MeSH)
• Child, Preschool (MeSH)
• Clinical Trials as Topic (MeSH)
• Female (MeSH)
• Fibrinolytic Agents (MeSH)
• Hematology (MeSH)
• Heparin (MeSH)
• Heparin, Low-Molecular-Weight (MeSH)
• Humans (MeSH)
• Incidence (MeSH)
• Infant (MeSH)
• Male (MeSH)
• Pediatrics (MeSH)
• Recurrence (MeSH)
• Risk (MeSH)
• Risk Factors (MeSH)
• Thrombosis (MeSH)
• Treatment Outcome (MeSH)

published in

• Hematology. American Society of Hematology. Education Program  Journal

keywords

• Adolescent
• Anticoagulants
• Child
• Child, Preschool
• Clinical Trials as Topic
• Female
• Fibrinolytic Agents
• Hematology
• Heparin
• Heparin, Low-Molecular-Weight
• Humans
• Incidence
• Infant
• Male
• Pediatrics
• Recurrence
• Risk
• Risk Factors
• Thrombosis
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1182/asheducation.v2012.1.439.3798661

PubMed ID

• 23233616

start page

• 439

end page

• 443

volume

• 2012

issue

• 1